乌干达门诊隐球菌抗原筛查与隐球菌脑膜炎患者有利基线特征及生存改善相关
研究前瞻性纳入2018年12月至2021年12月乌干达HIV合并隐球菌脑膜炎患者489例,比较接受门诊血隐球菌抗原(CrAg)筛查后转诊者与直接就诊者的结局。CrAg筛查组14天死亡率12% vs 非筛查组21%(HR 0.51,95%CI 0.32-0.83,P=0.006),且意识状态改变更少、脑脊液培养负荷和开放压力更低。
要点
- 489例中40%(194/489)接受血CrAg筛查并转诊,中位转诊时间2天(IQR 1-6)。
- CrAg筛查组14天死亡率12% vs 非筛查组21%(HR 0.51,95%CI 0.32-0.83,P=0.006)。
- CrAg筛查组意识状态改变29% vs 非筛查组41%(P=0.03),脑脊液培养负荷和开放压力更低。
核心结论
- 有CrAg筛查史的隐球菌脑膜炎患者生存率高于无筛查者。
- 多变量模型中意识状态改变是死亡率最强的预测因素。
- 作者认为CrAg筛查可在更早期阶段检出隐球菌脑膜炎,证据为有利的基线风险特征和明显更少的意识状态改变者。
研究设计与样本
- 前瞻性队列研究,2018年12月至2021年12月纳入乌干达HIV合并隐球菌脑膜炎患者489例。
- 参与者接受以两性霉素B为基础的联合治疗。
- 比较CrAg筛查后转诊医院者与直接就诊的症状性脑膜炎者的结局。
主要发现
- 489例中40%(194/489)接受血CrAg筛查并转诊,中位转诊时间2天(IQR 1-6)。
- CrAg筛查组14天死亡率12% vs 非筛查组21%(HR 0.51,95%CI 0.32-0.83,P=0.006)。
- CrAg筛查组意识状态改变29% vs 非筛查组41%(P=0.03)。
- CrAg筛查组脑脊液培养负荷中位数4570(IQR 11-100000)CFU/mL vs 非筛查组26900(IQR 182-324000)CFU/mL(P=0.01)。
- CrAg筛查组脑脊液开放压力中位数190(IQR 120-270)mmH2O vs 非筛查组225(IQR 140-340)mmH2O(P=0.004)。
临床怎么用
- 作者建议CrAg筛查可在更早期阶段检出隐球菌脑膜炎,依据为有利的基线风险特征和更少的意识状态改变者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unknown whether persons with symptomatic cryptococcal meningitis detected during routine blood cryptococcal antigen (CrAg) screening have better survival than persons presenting with overt meningitis. METHODS: We prospectively enrolled Ugandans with HIV and cryptocococcal meningitis from December 2018 to December 2021. Participants were treated with amphotericin-based combination therapy. We compared outcomes between persons who were CrAg screened then referred to hospital with those presenting directly to the hospital with symptomatic meningitis. RESULTS: Among 489 participants with cryptococcal meningitis, 40% (194/489) received blood CrAg screening and were referred to hospital (median time to referral 2 days; interquartile range [IQR], 1-6). CrAg-screened persons referred to hospital had lower 14-day mortality than non-CrAg-screened persons who presented directly to hospital with symptomatic meningitis (12% vs 21%; hazard ratio, .51; 95% confidence interval, .32-.83; P = .006). Fewer CrAg-screened participants had altered mental status versus non-CrAg-screened participants (29% vs 41%; P = .03). CrAg-screened persons had lower quantitative cerebrospinal fluid (CSF) culture burden (median [IQR], 4570 [11-100 000] vs 26 900 [182-324 000] CFU/mL; P = .01) and lower CSF opening pressures (median [IQR], 190 [120-270] vs 225 [140-340] mmH2O; P = .004) compared with non-CrAg-screened persons. CONCLUSIONS: Survival from cryptococcal meningitis was higher in persons with prior CrAg screening than those without CrAg screening. Altered mental status was the most potent predictor for mortality in a multivariate model. We suggest that CrAg screening detects cryptococcal meningitis at an earlier stage, as evidenced by a favorable baseline risk profile and notably fewer persons with altered mental status.
引用
- Levin AE, Bangdiwala AS, Nalintya E, et al. Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in Uganda. Clin Infect Dis. 2023. PMID: 35859045. doi:10.1093/cid/ciac599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。